Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herombopag in Tumors-associated Thrombocytopenia
NCT05350956Phase 2Unknown
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jun 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hetrombopag in Thrombocytopenia, sponsored by The First Affiliated Hospital of Zhengzhou University. Status: unknown.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT05350956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05350956.